Ledger.Open graph →
SEC Form D · Amendment · filed October 20, 2023

Auron Therapeutics, Inc

Offering
$48.2M
Sold
$38.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Newton, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

David A. Wilson · London, United KingdomDirectorDamian A. Maggio · Garden City, NYDirectorWilliam U. Martin · Ann Arbor, MIExec · DirectorRobert C. Wynne · Zionsville, INDirectorEdward Hansen · Camden, MEDirectorChristopher D. Guiffre · Newton, MAExecEric D. Shiozaki · Wellesley, MADirectorE. Smith · Baltimore, MDDirectorChristopher D. Guiffre · Newton, MAExecEric D. Shiozaki · Wellesley, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗